Overview

Gender

male

Dr. Krall is Associate Fellow, University of Pennsylvania Center for Bioethics, and Former Chief Medical Officer for GlaxoSmithKline (Retired). He is a member of the Executive Board of the Observational Medical Outcomes Partnership and of The Institute of Medicine Forum for Drug Discovery, Development and Translation. Dr. Krall holds a B.A. in mathematics from Swarthmore College, an M.D. from the University of Pittsburgh and completed his training in neurology and a fellowship in Clinical Pharmacology at the University of Rochester. Over 25 years in the pharmaceutical industry, Dr. Krall worked for four companies (Lorex Pharmaceuticals, Abbott Laboratories, Zeneca/AstraZeneca and GlaxoSmithKline), holding a variety of positions responsible for drug development, and safety of medicines.

He concluded his career as Senior Vice President and Chief Medical Officer for GlaxoSmithKline. Over his career he has overseen in some capacity the development of over 20 medicines, including Ambien, Hytrin for Benign Prostatic Hypertrophy, Depakote for Migraine and Bipolar Disorder, Nolvadex, Arimidex and Faslodex for breast cancer, Seroquel, Accolate, Diprivan, Iressa, Tykerb, and Entereg. Dr. Krall currently makes his home in Steamboat Springs, Colorado, where he and his wife own and operate Off the Beaten Path, an independent bookstore, coffeehouse and bakery caf?